The start-up specializes in the development of biocompatible nanorobots capable of delivering drugs to difficult-to-treat tumors more efficiently and safely than current therapies. Nanobots Therapeutics is the third investment in … Read more
Samuel Sánchez has successfully secured an “ERC Proof of Concept” grant, provided by the European Research Council (ERC), to explore the application of his nanorobots in the treatment of mucus-secreting tumors. This prestigious grant enables researchers to assess the feasibility and potential for knowledge transfer of their research projects.
Today marked the second edition of the BASF-ICIQ Innovation and Entrepreneurship Awards, which reward excellence in the field of chemistry. The biomedical company Nanobots Therapeutics S.L., led by Prof. Samuel … Read more
A team of researchers led by Samuel Sánchez from IBEC has monitored, for the first time, the behaviour of a swarm of nanorobots inside living mice. The study, published in the prestigious journal Science Robotics, reveals a coordinated movement, which could result in a very promising future in the field of precision medicine.
Research Professor Samuel Sánchez presented last March 3rd in Brussels the new generation of NanoBots and BioBots developed in his research group at Institute of Bioengineering of Catalonia (IBEC) in Barcelona.
The presentation took place during the European Research Council (ERC) Seminars. The audience was composed of scientific personnel of ERC, as well as a general audience from the European Commission.
With the title “Nanobots to 3D BioBots as future tools in robotics and medicine” Professor Sánchez presented during his seminar, fundamental aspects of catalytically powered nanoparticles -also called nanobots-, their applications in environmental remediation and also in future smart nanomedicine.